Publication:
Biphasic ROS production, p53 and BIK dictate the mode of cell death in response to DNA damage in colon cancer cells

dc.contributor.authorKütük, Özgür
dc.contributor.authorAytan, Nurgül
dc.contributor.authorKarakaş, Bahriye
dc.contributor.authorKurt, Aslı Giray
dc.contributor.authorAçıkbaş, Ufuk
dc.contributor.authorBaşaga, Hüveyda
dc.contributor.buuauthorTemel, Sehime Gülsün
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentHistoloji ve Embriyoloji Ana Bilim Dalı
dc.contributor.orcid0000-0002-9802-0880
dc.contributor.researcheridAAG-8385-2021
dc.contributor.scopusid6507885442
dc.date.accessioned2023-01-04T05:33:55Z
dc.date.available2023-01-04T05:33:55Z
dc.date.issued2017-03-31
dc.description.abstractNecrosis, apoptosis and autophagic cell death are the main cell death pathways in multicellular organisms, all with distinct and overlapping cellular and biochemical features. DNA damage may trigger different types of cell death in cancer cells but the molecular events governing the mode of cell death remain elusive. Here we showed that increased BH3-only protein BIK levels promoted cisplatin-and UV-induced mitochondrial apoptosis and biphasic ROS production in HCT-116 wild-type cells. Nonetheless, early single peak of ROS formation along with lysosomal membrane permeabilization and cathepsin activation regulated cisplatin-and UV-induced necrosis in p53-null HCT-116 cells. Of note, necrotic cell death in p53-null HCT-116 cells did not depend on BIK, mitochondrial outer membrane permeabilization or caspase activation. These data demonstrate how cancer cells with different p53 background respond to DNA-damaging agents by integrating distinct cell signaling pathways dictating the mode of cell death.
dc.identifier.citationKütük, Ö. vd. (2017). ''Biphasic ROS production, p53 and BIK dictate the mode of cell death in response to DNA damage in colon cancer cells''. Plos One, 12(8), 1-20.
dc.identifier.endpage20
dc.identifier.issn1932-6203
dc.identifier.issue8
dc.identifier.pubmed28796811
dc.identifier.scopus2-s2.0-85027268836
dc.identifier.startpage1
dc.identifier.urihttps://doi.org/10.1371/journal.pone.0182809
dc.identifier.urihttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0182809
dc.identifier.urihttp://hdl.handle.net/11452/30249
dc.identifier.volume12
dc.identifier.wos000407396200099
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherPublic Library Science
dc.relation.collaborationYurt içi
dc.relation.collaborationYurt dışı
dc.relation.journalPlos One
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.relation.tubitakSBAG-113S481
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectScience & technology - other topics
dc.subjectLysosomal membrane permeabilization
dc.subjectBh3-only protein bik
dc.subjectBcl-x-l
dc.subjectEndoplasmic-reticulum
dc.subjectMediated apoptosis
dc.subjectOxidative stress
dc.subjectFamily prote
dc.subjectInsinduction
dc.subjectMitochondria
dc.subjectActivation
dc.subject.emtreeBH3 protein
dc.subject.emtreeCaspase
dc.subject.emtreeCathepsin
dc.subject.emtreeCisplatin
dc.subject.emtreeProtein BIK
dc.subject.emtreeProtein p53
dc.subject.emtreeReactive oxygen metabolite
dc.subject.emtreeUnclassified drug
dc.subject.emtreeAntineoplastic agent
dc.subject.emtreeApoptosis regulatory protein
dc.subject.emtreeBIK protein, human
dc.subject.emtreeCisplatin
dc.subject.emtreeMembrane protein
dc.subject.emtreeProtein p53
dc.subject.emtreeReactive oxygen metabolite
dc.subject.emtreeTP53 protein, human
dc.subject.emtreeArticle
dc.subject.emtreeCancer cell
dc.subject.emtreeCancer cell destruction
dc.subject.emtreeCell death
dc.subject.emtreeCell membrane permeability
dc.subject.emtreeColon cancer
dc.subject.emtreeControlled study
dc.subject.emtreeDNA damage
dc.subject.emtreeEnzyme activation
dc.subject.emtreeIntracellular signaling
dc.subject.emtreeLysosome
dc.subject.emtreeMitochondrion
dc.subject.emtreeOuter membrane
dc.subject.emtreeProtein function
dc.subject.emtreeUltraviolet radiation
dc.subject.emtreeWild type
dc.subject.emtreeApoptosis
dc.subject.emtreeColon tumor
dc.subject.emtreeDrug effects
dc.subject.emtreeHCT 116 cell line
dc.subject.emtreeHuman
dc.subject.emtreeMembrane potential
dc.subject.emtreeMetabolism
dc.subject.meshAntineoplastic agents
dc.subject.meshApoptosis
dc.subject.meshApoptosis regulatory proteins
dc.subject.meshCisplatin
dc.subject.meshColonic neoplasms
dc.subject.meshDNA damage
dc.subject.meshHCT116 cells
dc.subject.meshHumans
dc.subject.meshLysosomes
dc.subject.meshMembrane potentials
dc.subject.meshMembrane proteins
dc.subject.meshReactive oxygen species
dc.subject.meshTumor suppressor protein p53
dc.subject.scopusCathepsins; Autolysosome; Lu 28-179
dc.subject.wosMultidisciplinary sciences
dc.titleBiphasic ROS production, p53 and BIK dictate the mode of cell death in response to DNA damage in colon cancer cells
dc.typeArticle
dc.wos.quartileQ1
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Histoloji ve Embriyoloji Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atWOS

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Temel_vd_2017.pdf
Size:
7.82 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: